Please login to the form below

Not currently logged in
Email:
Password:

Calchan names Zahid Ali as chief scientific officer

Ali joins from Pfizer where he was a senior director

edit-calchan-zahid-aliUK-based biotech company Clachan has appointed Zahid Ali as chief scientific officer.

Calchan works with a focus on research and development of novel molecules targeting pain and imflammation, complementing Ali's two decades of industry experience and extensive knowledge of the area.

Commenting on his appointment, Ali said: “I am very excited to be joining Calchan, which has a management team of enviable experience and a very successful track record in the sector. 

“I believe the company's products have significant potential and I am looking forward to working with the team to secure Calchan's position as a leader in this field.”

Ali joins from Pfizer, where he held the position of senior director of clinical research and was responsible for a number of early clinical development programmes focused on pain research.

He began his career at Merck Sharp and Dohme Research Laboratories UK before increasing his seniority at companies including GSK, where he worked as director of discovery medicine.

Brenda Reynolds, CEO at Calchan, added: “Zahid Ali's appointment is an important one as we continue to assemble a strong team to develop our assets at Calchan. I am delighted that Zahid has chosen to join us as his considerable experience and background, notably as a Clinical Director at Pfizer, will be invaluable.”

15th May 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics